3B Blackbio Dx share news, announcements and annual reports
NSE: 3BBLACKBIOBSE: 532067Healthcare ServicesSmall Cap
3B Blackbio Dx Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Oct 1996
Last close ₹1,381.60down ₹11.10 (0.80%)BSE ₹1,387.95
Share price at the NSE close on 27 Oct 2026. Previous close ₹1,392.70.
27 Oct: open ₹1,402.80, high ₹1,425.00, low ₹1,360.00
52-week range of BSE trades to 27 Oct 2026
₹1,083.50Low, 2 Jun 2026₹1,750.00High, 19 Jan 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,186 Cr1,399th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 21.35
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 3.66
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.36%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 18.7%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 14.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.01
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 8,38044.0% delivered
3B Blackbio Dx has 778 announcements on record, routine notices left out; 3 in the 30 days to 28 Oct 2026, the latest on 30 Sep 2026.
Last results date
The last board meeting held for results; the company has not yet given notice of the next.3B Blackbio Dx quarterly results
Aug13Thu
The board met on 13 Aug 2026 to consider quarterly results
Notice filed 5 Aug 2026
3B Blackbio Dx annual reports, presentations and earnings calls
The company's own documents, latest first.3B Blackbio Dx financials, year by year
Annual reports29
- Annual report, year to Mar 20267 Sep 2026
- Annual report, year to Mar 20254 Sep 2025
- Annual report, year to Mar 20242 Sep 2024
- Annual report, year to Mar 202329 Aug 2023
- Annual report, year to Mar 202227 Aug 2022
24 earlier reports
- Annual report, year to Mar 202128 Aug 2021
- Annual report, year to Mar 20202 Sep 2020
- Annual report, year to Mar 201930 Aug 2019
- Annual report, year to Mar 201827 Sep 2018
- Annual report, year to Mar 201726 Sep 2017
- Annual report, year to Mar 201622 Nov 2016
- Annual report, year to Mar 20159 Sep 2015
- Annual report, year to Mar 201410 Sep 2014
- Annual report, year to Mar 20131 Oct 2013
- Annual report, year to Mar 20121 Oct 2012
- Annual report, year to Mar 201130 Sep 2011
- Annual report, year to Mar 2010Filing day not known
- Annual report, year to Mar 2009Filing day not known
- Annual report, year to Mar 2008Filing day not known
- Annual report, year to Mar 2007Filing day not known
- Annual report, year to Mar 2006Filing day not known
- Annual report, year to Mar 2005Filing day not known
- Annual report, year to Mar 2004Filing day not known
- Annual report, year to Mar 2003Filing day not known
- Annual report, year to Mar 2002Filing day not known
- Annual report, year to Mar 2000Filing day not known
- Annual report, year to Mar 1999Filing day not known
- Annual report, year to Mar 1998Filing day not known
- Annual report, year to Mar 1997Filing day not known
Investor presentations31
- Investor's Presentation13 Aug 2026
- Investor's Presentation29 May 2026
- Investor's Presentation6 Feb 2026
- Investors's Presentation13 Nov 2025
- Investor Presentation14 Aug 2025
26 earlier presentations
- Investors Presentation28 May 2025
- Investor Presentation13 Feb 2025
- Investor Presentation13 Nov 2024
- Investor's Presentation12 Aug 2024
- Investor Presentation29 May 2024
- Investor Presentation10 Nov 2023
- Investor's Presentation11 Aug 2023
- Investor's Presentation29 May 2023
- Investor Presentation10 Aug 2022
- Investor Presentation29 Jul 2021
- Investor Presentation23 Jun 2021
- Investor Presentation5 Nov 2020
- Investor Presentation17 Sep 2020
- Investor Presentation31 Jul 2020
- Investor's Presentation26 Jun 2020
- Investor's Presentation11 Feb 2020
- Investor Presentation11 Nov 2019
- Investor Presentation29 Jul 2019
- Investor presentation for the year ended 31st march 201923 May 2019
- Investor Presentation24 Jan 2019
- Investor's Presentation10 Nov 2018
- Investor's Presentation7 Aug 2018
- Investor's Presentation24 May 2018
- Investors's Presentation9 Feb 2018
- Investor Presentation11 Nov 2017
- Kilpest Investor Presentation July 201731 Jul 2017
Earnings calls6
- Transcript of Analysts/Investors Call pertaining to the Financial Results for the quarter and Financial Year ended March 31, 20263 Jun 2026
- Audio Recording of Analysts/Investors Call pertaining to the Audited Financial Results for the quarter and financial year ended March 31, 20261 Jun 2026
- Transcript of Analysts/Investors Call pertaining to the Financial Results for the third quarter and nine months ended December 31, 202524 Feb 2026
- Audio Recording of Analysts/Investors Call pertaining to the Unaudited Financial Results for the third quarter and nine months ended December 31, 202521 Feb 2026
- Transcript of Analysts/Investors Call pertaining to the Financial Results for the first quarter ended June 30, 202523 Aug 2025
1 earlier call document
3B Blackbio Dx merger and demerger filings
Filings about a merger, demerger or scheme of arrangement, latest first.
Filings18
- Allotment of Shares pursuant to Scheme of Amalgamation28 Sep 2023
- Effectiveness of the Scheme11 Sep 2023
- Scheme of Amalgamation Between 3B BlackBio Biotech India Limited ("Company/Transferor Company") and Kilpest India Limited ("Transferee Company")10 Aug 2023
- Scheme of Amalgamation Between 3B BlackBio Biotech India Limited ("Company/Transferor Company") and Kilpest India Limited ("Transferee Company")8 Aug 2023
- Scheme of Amalgamation Between 3B BlackBio Biotech India Limited ("Company/Transferor Company") and Kilpest India Limited ("Transferee Company")20 Jul 2023
13 earlier filings
- Scheme Of Amalgamation between 3B BlackBio Biotech India Limited ("Company/Transferor Company") and Kilpest India Limited("Transferee Company")30 Jun 2023
- Scheme Of Amalgamation Between 3B BlackBio Biotech India Limited ('Company/Transferor Company') And Kilpest India Limited ('Transferee Company')10 May 2023
- Scheme Of Amalgamation between 3B Blackbio Biotech India Limited ('Company/Transferor Company') and Kilpest India Limited ('Transferee Company')12 Apr 2023
- Scheme Of Amalgamation Between 3B Blackbio Biotech India Limited ('Company/Transferor Company') And Kilpest India Limited ('Transferee Company')4 Apr 2023
- Scheme of Amalgamation between 3B BlackBio Biotech India Limited ('Company/Transferor Company') and Kilpest India Limited ('Transferee Company')10 Mar 2023
- Scheme of Amalgamation between 3B BlackBio Biotech India Limited ('Company/Transferor Company') and Kilpest India Limited ('Transferee Company')16 Jan 2023
- Disclosure of Material Event / Information under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.15 Dec 2022
- Amalgamation of 3B Blackbio Biotech India Limited, Subsidiary Company ("Transferor Company") and Kilpest India Limited, Holding Company ("Transferee Company").16 Sep 2022
- Amalgamation of 3B Blackbio Biotech India Limited, Subsidiary Company ("Transferor Company")and Kilpest India Limited, Holding'Company ("Transferee Company").26 Jul 2022
- NCLT Application for Scheme of Amalgamation.11 May 2022
- KILPEST INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/09/2020 ,inter alia, to consider and approve Scheme of Amalgamation between ....11 Sep 2020
- INTIMATION OF BOARD MEETING FOR CONSIDERATION OF 'SCHEME OF ARRANGEMENT'.30 Jan 2020
- INTIMATION OF BOARD MEETING FOR CONSIDERATION OF 'SCHEME OF ARRANGEMENT'.30 Jan 2020
3B Blackbio Dx share news and announcements
Newest first. Page 1 of 16.
Sep 2026
30 Sep · Meeting
29 Sep · Meeting
16 Sep · Analysts
11 Sep · Analysts
11 Sep · Analysts
7 Sep · Meeting
7 Sep · Dividend
5 Sep · Analysts
Aug 2026
29 Aug · Analysts
25 Aug · Analysts
13 Aug · Results
5 Aug · Board meeting
Meeting on 13 Aug 2026: quarterly results
Jul 2026
Jun 2026
25 Jun · Letter For Transfer Of Shares To Investor Education And Protection Fund (IEPF)
25 Jun · Disclosure
May 2026
29 May · Dividend
29 May · Results
20 May · Board meeting
Meeting on 29 May 2026: audited results and final dividend
Apr 2026
15 Apr · Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
4 Apr · Disclosure
Mar 2026
17 Mar · Analysts
12 Mar · Analysts
Feb 2026
19 Feb · Letter To Shareholders From CEO
Jan 2026
30 Jan · Board meeting
Meeting on 6 Feb 2026: quarterly results
Dec 2025
24 Dec · Disclosure
20 Dec · Analysts
15 Dec · Analysts
Nov 2025
29 Nov · Analysts
24 Nov · Analysts
13 Nov · Results
6 Nov · Board meeting
Meeting on 13 Nov 2025: quarterly results
How the price met the news
The latest 30. The first session after each announcement, beside the market. Moves to 29 Sep 2025 are on BSE closes, before the company traded on NSE.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.Delivery against usualDelivery against usual. The share of the session's volume delivered into demat accounts, rather than bought and sold again the same day, less its average over the twenty sessions before, in percentage points (pts). Delivery against usual in the glossary
- 1 Oct 2026Board or managers changeddown 3.72%−2.7 pts vs Nifty 500market median 0.0% · five sessions −10.5% (−8.5 pts vs Nifty 500) · volume 1.3× usual · delivery −17.0 pts against usual · The announcement
- 7 Sep 2026Dividendup 4.19%+4.6 pts vs Nifty 500market median 0.0% · five sessions −2.8% (−1.1 pts vs Nifty 500) · volume 0.7× usual · delivery −8.5 pts against usual · The announcement
- 1 Jun 2026Dividenddown 11.15%−10.2 pts vs Nifty 500market median 0.0% · five sessions −9.7% (−8.9 pts vs Nifty 500) · volume 3.5× usual · delivery −8.5 pts against usual · The announcement
- 20 May 2026Dividenddown 0.52%−0.8 pts vs Nifty 500market median 0.0% · five sessions −5.6% (−7.3 pts vs Nifty 500) · volume 0.4× usual · delivery −12.0 pts against usual · The announcement
- 29 Sep 2025Board or managers changedup 2.75%+2.6 pts vs Nifty 500market median 0.0% · five sessions +3.9% (+1.9 pts vs Nifty 500) · volume 1.7× usual · The announcement
- 5 Sep 2025Dividendup 2.75%+2.7 pts vs Nifty 500market median 0.0% · five sessions −0.7% (−1.9 pts vs Nifty 500) · volume 2.1× usual · The announcement
- 29 May 2025Dividenddown 18.89%−19.2 pts vs Nifty 500market median 0.0% · five sessions −12.4% (−12.5 pts vs Nifty 500) · volume 15.8× usual · The announcement
- 20 May 2025Dividenddown 0.36%+0.9 pts vs Nifty 500market median 0.0% · five sessions +11.2% (+11.0 pts vs Nifty 500) · volume 1.2× usual · The announcement
- 30 Sep 2024Board or managers changedup 2.53%+3.5 pts vs Nifty 500market median 0.0% · five sessions −2.4% (+2.9 pts vs Nifty 500) · volume 1.3× usual · The announcement
- 3 Sep 2024Dividendup 3.73%+3.6 pts vs Nifty 500market median 0.0% · five sessions −0.9% (+0.2 pts vs Nifty 500) · volume 1.5× usual · The announcement
20 earlier announcements
- 2 Sep 2024Dividendup 3.74%+3.6 pts vs Nifty 500market median 0.0% · five sessions +5.1% (+6.2 pts vs Nifty 500) · volume 0.6× usual · The announcement
- 30 May 2024Dividendup 12.24%+13.3 pts vs Nifty 500market median 0.0% · five sessions +7.2% (+8.2 pts vs Nifty 500) · volume 8.7× usual · The announcement
- 30 Aug 2023Dividendup 0.79%+0.5 pts vs Nifty 500market median 0.0% · five sessions +35.7% (+33.8 pts vs Nifty 500) · volume 1.0× usual · The announcement
- 29 May 2023Dividenddown 2.74%−3.2 pts vs Nifty 500market median 0.0% · five sessions −5.6% (−6.3 pts vs Nifty 500) · volume 5.5× usual · The announcement
- 25 Apr 2023Dividendup 1.56%+1.4 pts vs Nifty 500market median 0.0% · five sessions +1.8% (−0.7 pts vs Nifty 500) · volume 0.6× usual · The announcement
- 27 May 2022Dividendup 1.31%+0.2 pts vs Nifty 500market median 0.0% · five sessions +0.5% (−2.7 pts vs Nifty 500) · volume 0.6× usual · The announcement
- 25 Apr 2022Dividenddown 2.45%−1.0 pts vs Nifty 500market median 0.0% · five sessions −5.0% (−4.3 pts vs Nifty 500) · volume 0.4× usual · The announcement
- 23 Jun 2021Dividenddown 5.07%−4.6 pts vs Nifty 500market median 0.0% · five sessions +48.9% (+48.9 pts vs Nifty 500) · volume 2.2× usual · The announcement
- 11 May 2021Dividenddown 0.08%+0.1 pts vs Nifty 500market median 0.0% · five sessions +0.2% (−1.1 pts vs Nifty 500) · volume 0.3× usual · The announcement
- 8 Jun 2020Dividendup 6.18%+5.9 pts vs Nifty 500market median 0.0% · five sessions +36.2% (+37.5 pts vs Nifty 500) · volume 1.4× usual · The announcement
- 12 Mar 2020Dividenddown 9.66%−1.3 pts vs Nifty 500market median 0.0% · five sessions −16.8% (+1.9 pts vs Nifty 500) · volume 1.3× usual · The announcement
- 5 Mar 2020Dividendup 4.83%+4.6 pts vs Nifty 500market median 0.0% · five sessions −15.6% (−0.9 pts vs Nifty 500) · volume 0.4× usual · The announcement
- 1 Oct 2019Dividendup 0.64%+1.8 pts vs Nifty 500market median 0.0% · five sessions +4.9% (+6.6 pts vs Nifty 500) · volume 0.9× usual · The announcement
- 29 May 2019Dividenddown 5.77%−5.2 pts vs Nifty 500market median 0.0% · five sessions −1.9% (−2.6 pts vs Nifty 500) · volume 1.0× usual · The announcement
- 27 May 2019Dividendup 9.83%+9.0 pts vs Nifty 500market median 0.0% · five sessions +1.6% (+0.8 pts vs Nifty 500) · volume 8.1× usual · The announcement
- 24 May 2019Dividendup 6.43%+4.7 pts vs Nifty 500market median 0.0% · five sessions +9.4% (+6.6 pts vs Nifty 500) · volume 3.5× usual · The announcement
- 30 Apr 2019Dividenddown 2.29%−2.0 pts vs Nifty 500market median 0.0% · five sessions −5.6% (−3.2 pts vs Nifty 500) · volume 0.3× usual · The announcement
- 18 Mar 2019Credit ratingdown 7.57%−7.8 pts vs Nifty 500market median 0.0% · five sessions −12.7% (−11.7 pts vs Nifty 500) · volume 0.6× usual · The announcement
- 30 Aug 2018Dividendup 2.11%+2.1 pts vs Nifty 500market median 0.0% · five sessions +2.1% (+4.2 pts vs Nifty 500) · volume 0.3× usual · The announcement
- 24 May 2018Dividenddown 4.99%−5.5 pts vs Nifty 500market median 0.0% · five sessions −9.4% (−11.4 pts vs Nifty 500) · volume 5.1× usual · The announcement
Figures filed again
Lines the company later filed with a different value, rupee lines in ₹ crore and per-share lines in rupees.
| Line | Period | Accounts | First filed | Filed again | Change. The value filed again less the value first filed, as a per cent of the first. | First filed on | Filed again on |
|---|---|---|---|---|---|---|---|
| Face value of a share | Year to date to Sep 2025 | Consolidated | 26,243.65 | 10.00 | −100.0% | 13 Nov 2025 | 20 Dec 2025 |
| Face value of a share | Quarter to Sep 2025 | Consolidated | 26,243.65 | 10.00 | −100.0% | 13 Nov 2025 | 20 Dec 2025 |
| Face value of a share | Year to date to Sep 2025 | Standalone | 26,421.76 | 10.00 | −100.0% | 13 Nov 2025 | 20 Dec 2025 |
| Face value of a share | Quarter to Sep 2025 | Standalone | 26,421.76 | 10.00 | −100.0% | 13 Nov 2025 | 20 Dec 2025 |
| Employee costs | Quarter to Jun 2023 | Standalone | 0.46 | 1.08 | +132.8% | 11 Aug 2023 | 29 Nov 2023 |
| Depreciation and amortisation | Quarter to Jun 2023 | Standalone | 0.08 | 0.18 | +129.0% | 11 Aug 2023 | 29 Nov 2023 |
| Other expenses | Quarter to Jun 2023 | Standalone | 0.38 | 1.62 | +327.3% | 11 Aug 2023 | 29 Nov 2023 |
| Total expenses | Quarter to Jun 2023 | Standalone | 2.54 | 6.72 | +164.9% | 11 Aug 2023 | 29 Nov 2023 |
| Profit before tax | Quarter to Jun 2023 | Standalone | 0.32 | 9.45 | +2,833.2% | 11 Aug 2023 | 29 Nov 2023 |
| Tax | Quarter to Jun 2023 | Standalone | 0.08 | 1.98 | +2,347.0% | 11 Aug 2023 | 29 Nov 2023 |